JUAN PABLO RODRIGO TAPIA-rekin lankidetzan egindako argitalpenak (8)

2023

  1. Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways

    Biomedicine and Pharmacotherapy, Vol. 161

2020

  1. Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications

    Cancers, Vol. 12, Núm. 4

2019

  1. The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042

    Journal of Clinical Medicine, Vol. 8, Núm. 8

  2. The differential impact of SRC expression on the prognosis of patients with head and neck squamous cell carcinoma

    Cancers, Vol. 11, Núm. 11

  3. The novel role of SOX2 as an early predictor of cancer risk in patients with laryngeal precancerous lesions

    Cancers, Vol. 11, Núm. 3

2018

  1. Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients

    Journal of Clinical Medicine, Vol. 7, Núm. 12

  2. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway

    Neoplasia (United States), Vol. 20, Núm. 1, pp. 44-56

2016

  1. Osteosarcoma: Cells-of-Origin, Cancer stem cells, and targeted therapies

    Stem Cells International, Vol. 2016